Current Hypertension Reports

, 16:455

Blood Pressure and Cardiovascular Effects of New and Emerging Antidiabetic Agents

  • Pelbreton C. BalfourJr.
  • Carlos J. Rodriguez
  • Keith C. Ferdinand
Hypertension and Obesity (E Reisin, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Hypertension and Obesity

Abstract

Despite remarkable declines in US cardiovascular disease morbidity and mortality over the last several decades, the prevalence of risk factors such as type 2 diabetes and hypertension remains high, associated with increasing obesity rates. Although optimal glycemic control remains a primary focus to decrease the disease burden, the FDA has issued guidance recommendations for documenting cardiovascular disease-related safety with research trials on new antidiabetic agents with more demanding requirements compared to past approval of existing therapies. This review will discuss the public health impact of type 2 diabetes, specifically with comorbid hypertension; mechanisms of action of the newest antidiabetic drug classes; and preliminary findings and potential clinical significance of the favorable blood pressure and body weight effects of the sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists; and additionally discuss two recent large cardiovascular outcome trials with dipeptidyl peptidase-4 inhibitors.

Keywords

Diabetes Hypertension Antidiabetic drugs Cardiovascular disease Sodium-glucose cotransporter 2 inhibitors Glucagon-like peptide-1 receptor agonists Dipeptidyl peptidase-4 inhibitors Systolic blood pressure Obesity 

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Pelbreton C. BalfourJr.
    • 1
  • Carlos J. Rodriguez
    • 1
  • Keith C. Ferdinand
    • 2
    • 3
  1. 1.Division of Public Health SciencesWake Forest School of MedicineWinston-SalemUSA
  2. 2.Heart and Vascular InstituteTulane University School of MedicineNew OrleansUSA
  3. 3.Tulane School of MedicineTulane Heart and Vascular InstituteNew OrleansUSA

Personalised recommendations